Immune modulator

0 marketed 2 in Phase 3 1 in Phase 2

This page covers all Immune modulator drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CD8+ T cells, Unknown.

Targets

CD8+ T cells · Unknown

Phase 3 pipeline (2)

Phase 2 pipeline (1)